Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samples
出版年份 2021 全文链接
标题
Clinical characterization and immunosuppressive regulation of CD161 (KLRB1) in glioma through 916 samples
作者
关键词
-
出版物
CANCER SCIENCE
Volume 113, Issue 2, Pages 756-769
出版商
Wiley
发表日期
2021-12-09
DOI
10.1111/cas.15236
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis
- (2021) Nathan D. Mathewson et al. CELL
- Deciphering the Prognostic Implications of the Components and Signatures in the Immune Microenvironment of Pancreatic Ductal Adenocarcinoma
- (2021) Rong Tang et al. Frontiers in Immunology
- Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Gliomas
- (2021) Zheng Zhao et al. GENOMICS PROTEOMICS & BIOINFORMATICS
- Immunotherapy for Malignant Glioma: Current Status and Future Directions
- (2020) Hongxiang Wang et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Immunotherapy for glioma: Current management and future application
- (2020) Shengchao Xu et al. CANCER LETTERS
- Single-Cell RNA-Sequencing Shift in the Interaction Pattern Between Glioma Stem Cells and Immune Cells During Tumorigenesis
- (2020) You Zhai et al. Frontiers in Immunology
- Redox Regulator GLRX Is Associated With Tumor Immunity in Glioma
- (2020) Yuanhao Chang et al. Frontiers in Immunology
- Clinical practice guidelines for the management of adult diffuse gliomas
- (2020) Tao Jiang et al. CANCER LETTERS
- CD161 Is Expressed in a Subset of T-Cell Prolymphocytic Leukemia Cases and Is Useful for Disease Follow-up
- (2019) Scott R Gilles et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Immune Cytolytic Activity Is Associated With Genetic and Clinical Properties of Glioma
- (2019) Zhi-liang Wang et al. Frontiers in Immunology
- Siglecs, Novel Immunotherapy Targets, Potentially Enhance The Effectiveness of Existing Immune Checkpoint Inhibitors in Glioma Immunotherapy
- (2019) Guan-Zhang Li et al. OncoTargets and Therapy
- Current state of immunotherapy for glioblastoma
- (2018) Michael Lim et al. Nature Reviews Clinical Oncology
- CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges
- (2018) Stephen J Bagley et al. NEURO-ONCOLOGY
- Immunotherapies for malignant glioma
- (2017) Vassiliki A. Boussiotis et al. ONCOGENE
- Molecular and clinical characterization of TIM-3 in glioma through 1,024 samples
- (2017) Guanzhang Li et al. OncoImmunology
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Molecular and clinical characterization of PD-L1 expression at transcriptional level via 976 samples of brain glioma
- (2016) Zheng Wang et al. OncoImmunology
- Emerging treatment strategies for glioblastoma multiforme
- (2014) S. K. Carlsson et al. EMBO Molecular Medicine
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search